Serum 25-hydroxyvitamin D status in hip and spine-fracture patients in Japan
- 173 Downloads
Serum 25-hydroxyvitamin D (25(OH)D) is used as an index that reflects the level of vitamin D. We have previously reported, on the basis of a study in Sado in Niigata, that patients with hip fracture have lower serum 25(OH)D levels than non-hip-fracture cases. In this study, the serum 25(OH)D status in hip-fracture cases was examined in four regions in Japan. Although most hip-fracture patients have experienced past spine-compression fractures, the relationship of these fractures and 25(OH)D is unknown. Therefore, we also examined the 25(OH)D level in spine-compression fracture patients in the same locations and time periods.
The levels of 25(OH)D, intact parathyroid hormone (intact PTH), undercarboxylated osteocalcin (ucOC), urine N-terminal crosslinking telopeptide of type I collagen (NTX), and bone mineral density were examined in patients with hip and spine fracture due to osteoporosis in several regions in Japan.
There were no significant differences in age, BMI, serum 25(OH)D, serum intact PTH, and serum ucOC among the regions. Levels of serum 25(OH)D were low in patients with hip fracture and spine fracture. The average serum 25(OH)D level was significantly lower in hip-fracture patients than in spine-fracture patients (16.3 vs. 18.1 ng/mL, P < 0.05). High serum ucOC was found in 37% of hip-fracture patients and 44% of spine-fracture patients.
Both hip and spine-fracture patients have vitamin D insufficiency, with similar results found in elderly patients in four areas of Japan. The severity of this condition tends to be more serious in hip-fracture patients than in spine-fracture patients.
- 6.Nakamura K. Vitamin D insufficiency in Japanese populations: from the viewpoint of the prevention of osteoporosis. J Bone Miner Metab 2006;24(1):1–6 (Review).Google Scholar
- 7.Okano T, Tsugawa N, Suhara Y, Tanaka K, Ishida H, Uenishi K, Kubota E, Fukunaga M, Hosoi T, Shiraki M. Vitamin D status and bone metabolic markers of adult, especially elderly women in Japan. Osteoporos Jpn 2004;12:76–79 (in Japanese).Google Scholar
- 8.Hagino H, Yamamoto K, Ohshiro H, Nakamura T, Kishimoto H, Nose T. Changing Incidence of hip, distal radius and proximal humerus fractures in Tottori Prefecture, Japan. Bone (NY). 1999;24:265–70.Google Scholar
- 14.Yamaoka M, Inomata K, Wakiya S, Baba H, Yamashita H, Yamashita H, Noguchi S. Zenjidou denkikagaku hakkoumeneki sokuteisouchi “ECLusys 2010” ni yoru fukukoujousenn horumon sokutei no kentou. Jpn J Med Pharm Sci 2001;46(5):753–758 (in Japanese).Google Scholar
- 15.Thomas L. Parathyroid hormone (PTH). Clinical laboratory diagnosis. 1st English ed. Frankfurt: TH-Books; 1998. pp. 248–250.Google Scholar
- 17.World Health Organization. Prevention and management of osteoporosis, technical report series 2003; No. 921, pp. 38–31.Google Scholar
- 19.Shiraki M, Aoki C, Yamazaki N, Ito Y, Tsugawa N, Suhara Y, Okano T. Clinical assessment of undercarboxylated osteocalcin measurement in serum using an electrochemiluminescence immunoassay: Establishments of cut-off value to determine vitamin K insufficiency in bone and to predict fracture leading to clinical use of vitamin K2. Jpn J Med Pharm Sci 2007;57(4):537-546 (in Japanese).Google Scholar
- 20.Nisimura J, Arai N, Tohmatsu J. Measurement of serum undercarboxylated osteocalcin by electro chemiluminescence immunoassay with the “Picolumi ucOC “kit. Jpn J Med Pharm Sci 2007;57(4):523–535 (in Japanese).Google Scholar
- 21.Kaneki M, Hodges SJ, Hosoi T, Fujiwara S, Lyons A, Crean SJ, Ishida N, Nakagawa M, Takechi M, Sano Y, Mizuno Y, Hoshino S, Miyao M, Inoue S, Horiki K, Shiraki M, Ouchi Y, Orimo H. Japanese fermented soybean food as the major determinant of the large geographic difference in circulating levels of vitamin K2: possible implications for hip-fracture risk. Nutrition. 2001;4:315–21.CrossRefGoogle Scholar